Aperio Group’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
$5.85M Buy
23,408
+37
+0.2% +$9.25K 0.02% 758
2020
Q3
$5.29M Buy
23,371
+594
+3% +$135K 0.02% 718
2020
Q2
$3.97M Sell
22,777
-269
-1% -$46.9K 0.01% 811
2020
Q1
$2.91M Sell
23,046
-13
-0.1% -$1.64K 0.01% 856
2019
Q4
$3.52M Buy
23,059
+450
+2% +$68.7K 0.01% 863
2019
Q3
$2.99M Sell
22,609
-672
-3% -$88.9K 0.01% 890
2019
Q2
$3.3M Sell
23,281
-343
-1% -$48.7K 0.01% 863
2019
Q1
$3.43M Sell
23,624
-1,118
-5% -$162K 0.01% 822
2018
Q4
$2.8M Sell
24,742
-664
-3% -$75.1K 0.01% 853
2018
Q3
$3.42M Sell
25,406
-476
-2% -$64K 0.02% 816
2018
Q2
$2.91M Buy
25,882
+233
+0.9% +$26.2K 0.01% 854
2018
Q1
$2.74M Buy
25,649
+37
+0.1% +$3.95K 0.01% 862
2017
Q4
$2.8M Buy
25,612
+739
+3% +$80.9K 0.01% 865
2017
Q3
$2.69M Buy
24,873
+1,467
+6% +$158K 0.02% 827
2017
Q2
$2.37M Buy
23,406
+1,236
+6% +$125K 0.01% 845
2017
Q1
$1.99M Sell
22,170
-7
-0% -$630 0.01% 870
2016
Q4
$1.69M Buy
22,177
+3,779
+21% +$288K 0.01% 890
2016
Q3
$1.53M Sell
18,398
-4,790
-21% -$399K 0.01% 935
2016
Q2
$1.91M Buy
23,188
+5,055
+28% +$417K 0.01% 825
2016
Q1
$1.38M Buy
18,133
+2,470
+16% +$188K 0.01% 919
2015
Q4
$1.26M Buy
15,663
+990
+7% +$79.6K 0.01% 913
2015
Q3
$932K Buy
14,673
+4,143
+39% +$263K 0.01% 1004
2015
Q2
$741K Buy
10,530
+2,024
+24% +$142K 0.01% 1117
2015
Q1
$674K Buy
8,506
+517
+6% +$41K 0.01% 1114
2014
Q4
$508K Buy
7,989
+1,569
+24% +$99.8K 0.01% 1214
2014
Q3
$384K Sell
6,420
-262
-4% -$15.7K 0.01% 1263
2014
Q2
$358K Buy
6,682
+2,010
+43% +$108K 0.01% 1294
2014
Q1
$282K Buy
+4,672
New +$282K ﹤0.01% 1658
2013
Q4
Sell
-4,383
Closed -$203K 1665
2013
Q3
$203K Buy
+4,383
New +$203K ﹤0.01% 1641